Joe Rogan Experience #2319 - Rick Doblin
4May 9, 2025
Summary
In this episode, Rick Doblin discusses the advancements in psychedelic therapy, particularly focusing on MDMA-assisted therapy for PTSD. As the founder of MAPS, he highlights the organization's role in promoting evidence-based treatment approaches while working towards ending the prohibition of psychedelics. The conversation underscores the upcoming Psychedelic Science 2025 conference as a pivotal moment for the field.
Key Takeaways
- 1Rick Doblin, Ph.D., is the founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS).
- 2MAPS was established in 1986 to advance evidence-based psychedelic therapy and end prohibition.
- 3Lykos Therapeutics, formerly MAPS Public Benefit Corporation, is developing MDMA-assisted therapy for PTSD.
- 4The Psychedelic Science 2025 conference is scheduled for June 16–20 in Denver, Colorado.
Description
In this episode, Rick Doblin discusses the advancements in psychedelic therapy, particularly focusing on MDMA-assisted therapy for PTSD. As the founder of MAPS, he highlights the organization's role in promoting evidence-based treatment approaches while working towards ending the prohibition of psychedelics. The conversation underscores the upcoming Psychedelic Science 2025 conference as a pivotal moment for the field.